Surprisingly, higher expression levels of Foxp3 mRNA molecules in the population of CD4+ cells has been demonstrated in the active SLE in comparison with the control group and patients with inactive SLE (Lee et al. 2008). This evidence concerns the gene CD4 and systemic lupus erythematosus.